{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:15:42Z","timestamp":1783642542753,"version":"3.55.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Uludag University (Bursa, Turkey)","award":["KUAP(T)-2015\/6"],"award-info":[{"award-number":["KUAP(T)-2015\/6"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.cbi.2017.12.003","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T11:16:15Z","timestamp":1512731775000},"page":"51-58","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"special_numbering":"C","title":["Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells"],"prefix":"10.1016","volume":"280","author":[{"given":"Nazl\u0131han","family":"Aztopal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Erkisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elif","family":"Erturk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Engin","family":"Ulukaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asuman Hatice","family":"Tokullugil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferda","family":"Ari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cbi.2017.12.003_bib1","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1002\/ijc.27841","article-title":"An international comparison of male and female breast cancer incidence rates","volume":"132","author":"Ly","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"9","key":"10.1016\/j.cbi.2017.12.003_bib2","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.ejso.2006.06.001","article-title":"Patterns of breast cancer relapse","volume":"32","author":"Elder","year":"2006","journal-title":"Eur. J. Surg. Oncol."},{"issue":"4","key":"10.1016\/j.cbi.2017.12.003_bib3","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1158\/0008-5472.CAN-05-3153","article-title":"Cancer stem cells: an old idea\u2013a paradigm shift","volume":"66","author":"Wicha","year":"2006","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.cbi.2017.12.003_bib4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.3906\/biy-1406-93","article-title":"Cancer stem cells: emerging actors in both basic and clinical cancer research","volume":"38","author":"Karakas","year":"2014","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.cbi.2017.12.003_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.semcancer.2014.08.004","article-title":"Implications of stemness-related signaling pathways in breast cancer response to therapy","volume":"31","author":"Angeloni","year":"2015","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.cbi.2017.12.003_bib6","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"6127","key":"10.1016\/j.cbi.2017.12.003_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1126\/science.1230184","article-title":"Epigenetic reprogramming in cancer","volume":"339","author":"Suv\u00e0","year":"2013","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.cbi.2017.12.003_bib8","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.1158\/0008-5472.CAN-08-3907","article-title":"Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome","volume":"69","author":"Elsheikh","year":"2009","journal-title":"Cancer Res."},{"issue":"37","key":"10.1016\/j.cbi.2017.12.003_bib9","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1038\/sj.onc.1210599","article-title":"HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention","volume":"26","author":"Yang","year":"2007","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.cbi.2017.12.003_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/sj.bjc.6604199","article-title":"Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy","volume":"98","author":"Weichert","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.lungcan.2011.02.019","article-title":"Expression of histone deacetylase 1 correlates with a poor prognosis in patients with adenocarcinoma of the lung","volume":"74","author":"Minamiya","year":"2011","journal-title":"Lung Cancer"},{"issue":"148","key":"10.1016\/j.cbi.2017.12.003_bib12","article-title":"Histone deacetylase (HDAC)-1, -2, -4 and -6 expression in human pancreatic adenocarcinoma: associations with clinicopathological parameters, tumor proliferative capacity and patients' survival","volume":"15","author":"Giaginis","year":"2015","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.cbi.2017.12.003_bib13","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.lfs.2016.02.092","article-title":"Alterations in histone deacetylase 8 lead to cell migration and poor prognosis in breast cancer","volume":"151","author":"Hsieh","year":"2016","journal-title":"Life Sci."},{"issue":"12","key":"10.1016\/j.cbi.2017.12.003_bib14","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1038\/onc.2016.337","article-title":"Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer","volume":"36","author":"Witt","year":"2017","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.cbi.2017.12.003_bib15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrd1930","article-title":"Epigenetic therapy of cancer: past, present and future","volume":"5","author":"Yoo","year":"2006","journal-title":"Nat. Rev. Drug Discov."},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib16","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/1078-0432.CCR-11-0946","article-title":"Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma","volume":"18","author":"Landreville","year":"2012","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.cbi.2017.12.003_bib17","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1186\/bcr3192","article-title":"Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat","volume":"14","author":"Tate","year":"2012","journal-title":"Breast Cancer Res."},{"issue":"12","key":"10.1016\/j.cbi.2017.12.003_bib18","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.18632\/oncotarget.1314","article-title":"Combinatorial antitumor effect of HDAC and the PI3K-Akt-mTOR pathway inhibition in a Pten defecient model of prostate cancer","volume":"4","author":"Ellis","year":"2013","journal-title":"Oncotarget"},{"issue":"6","key":"10.1016\/j.cbi.2017.12.003_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s10565-016-9347-8","article-title":"Histone deacetylase inhibitor induces cell apoptosis and cycle arrest in lung cancer cells via mitochondrial injury and p53 up-acetylation","volume":"32","author":"Bao","year":"2016","journal-title":"Cell Biol. Toxicol."},{"issue":"11","key":"10.1016\/j.cbi.2017.12.003_bib20","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1111\/cas.12271","article-title":"Alteration of cancer stem cell-like phenotype by histone deacetylase inhibitors in squamous cell carcinoma of the head and neck","volume":"104","author":"Chikamatsu","year":"2013","journal-title":"Cancer Sci."},{"issue":"23","key":"10.1016\/j.cbi.2017.12.003_bib21","doi-asserted-by":"crossref","first-page":"6520","DOI":"10.1158\/1078-0432.CCR-13-0877","article-title":"The histone deacetylase inhibitor abexinostat induces cancer stem cells differentiation in breast cancer with low Xist expression","volume":"19","author":"Salvador","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.cbi.2017.12.003_bib22","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1021\/acs.jmedchem.5b00126","article-title":"Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells","volume":"58","author":"Di Pompo","year":"2015","journal-title":"J. Med. Chem."},{"issue":"3-4","key":"10.1016\/j.cbi.2017.12.003_bib23","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s13148-010-0012-4","article-title":"Histone deacetylase (HDAC) inhibitors in recent clinical trials for cancer therapy","volume":"1","author":"Wagner","year":"2010","journal-title":"Clin. Epigenetics"},{"key":"10.1016\/j.cbi.2017.12.003_bib24","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/479364","article-title":"Molecular and therapeutic potential and toxicity of valproic acid","author":"Chateauvieux","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"issue":"1","key":"10.1016\/j.cbi.2017.12.003_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.biocel.2008.08.019","article-title":"Epigenetic reprogramming of breast cancer cells by valproic acid occurs regardless of estrogen receptor status","volume":"41","author":"Travaglini","year":"2009","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib26","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.canlet.2007.10.006","article-title":"Valproic acid is a selective antiproliferative agent in estrogen-sensitive breast cancer cells","volume":"259","author":"Fortunati","year":"2008","journal-title":"Cancer Lett."},{"issue":"3","key":"10.1016\/j.cbi.2017.12.003_bib27","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.ijrobp.2009.09.052","article-title":"Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions","volume":"76","author":"Debeb","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"10","key":"10.1016\/j.cbi.2017.12.003_bib28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1586\/14737140.2014.940329","article-title":"Could valproic acid be an effective anticancer agent? The evidence so far","volume":"14","author":"Brodie","year":"2014","journal-title":"Expert Rev. Anticancer Ther"},{"issue":"24","key":"10.1016\/j.cbi.2017.12.003_bib29","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1002\/1873-3468.12496","article-title":"Both bulk and cancer stem cell subpopulations in triple-negative breast cancer are susceptible to Wnt, HDAC, and ER\u03b1 coinhibition","volume":"590","author":"Sulaiman","year":"2016","journal-title":"FEBS Lett."},{"issue":"17","key":"10.1016\/j.cbi.2017.12.003_bib30","doi-asserted-by":"crossref","first-page":"5580","DOI":"10.1016\/j.bmc.2015.07.026","article-title":"Addition of niclosamide to palladium (II) saccharinate complex of terpyridine results in enhanced cytotoxic activity inducing apoptosis on cancer stem cells of breast cancer","volume":"23","author":"Karakas","year":"2015","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.cbi.2017.12.003_bib31","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bmc.2016.10.032","article-title":"A trans-platinum (II) complex induces apoptosis in cancer stem cells of breast cancer","volume":"25","author":"Aztopal","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"24","key":"10.1016\/j.cbi.2017.12.003_bib32","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1093\/jnci\/djj495","article-title":"The response of CD24\u2212\/low\/CD44+ breast cancer\u2013initiating cells to radiation","volume":"98","author":"Phillips","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib33","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/bcr1982","article-title":"Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy","volume":"10","author":"Fillmore","year":"2008","journal-title":"Breast Cancer Res."},{"issue":"9","key":"10.1016\/j.cbi.2017.12.003_bib34","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/jnci\/djn123","article-title":"Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy","volume":"100","author":"Li","year":"2008","journal-title":"J. Natl. Cancer Inst."},{"issue":"3","key":"10.1016\/j.cbi.2017.12.003_bib35","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/s10549-006-9459-6","article-title":"Inhibition of histone deacetylase enhances the anti-proliferative action of antiestrogens on breast cancer cells and blocks tamoxifen-induced proliferation of uterine cells","volume":"105","author":"Hodges-Gallagher","year":"2007","journal-title":"Breast Cancer Res. Treat."},{"issue":"1\u20132","key":"10.1016\/j.cbi.2017.12.003_bib36","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-011-1085-x","article-title":"VPA inhibits breast cancer cell migration by specifically targeting HDAC2 and down-regulating Survivin","volume":"361","author":"Zhang","year":"2012","journal-title":"Mol. Cell. Biochem."},{"issue":"13","key":"10.1016\/j.cbi.2017.12.003_bib37","doi-asserted-by":"crossref","first-page":"5506","DOI":"10.1158\/0008-5472.CAN-05-0626","article-title":"Isolation and in vitro propagation of tumourigenic breast cancer cells with stem\/progenitor cell propertie","volume":"65","author":"Ponti","year":"2005","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.cbi.2017.12.003_bib38","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1002\/stem.1219","article-title":"Histone deacetylase inhibitors stimulate dedifferentiation of human breast cancer cells through WNT\/\u03b2-catenin signaling","volume":"30","author":"Debeb","year":"2012","journal-title":"Stem Cells"},{"issue":"3","key":"10.1016\/j.cbi.2017.12.003_bib39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1586\/erm.10.14","article-title":"Utilization of cytokeratin-based biomarkers for pharmacodynamic studies","volume":"10","author":"Linder","year":"2010","journal-title":"Expert Rev. Mol. Diagn"},{"issue":"6","key":"10.1016\/j.cbi.2017.12.003_bib40","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/cbf.1774","article-title":"Apoptosis: why and how does it occur in biology?","volume":"29","author":"Ulukaya","year":"2011","journal-title":"Cell. biochem. Funct."},{"issue":"6","key":"10.1016\/j.cbi.2017.12.003_bib41","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1038\/cdd.2009.184","article-title":"Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features","volume":"17","author":"Berghe","year":"2010","journal-title":"Cell. Death Differ."},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib42","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.canlet.2011.01.013","article-title":"Targeting apoptosis pathways in cancer stem cells","volume":"332","author":"Signore","year":"2013","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib43","first-page":"4535","article-title":"Induction of apoptosis and acetylation of histone H3 and H4 by arctigenin in the human melanoma cell line SK-MEL-28","volume":"2","author":"Jeong","year":"2011","journal-title":"Food Nutr. Sci."},{"issue":"8","key":"10.1016\/j.cbi.2017.12.003_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/35085008","article-title":"Four deaths and a funeral: from caspases to alternative mechanisms","volume":"2","author":"Leist","year":"2001","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"315","key":"10.1016\/j.cbi.2017.12.003_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1042\/bj3150021","article-title":"Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD. FMK) inhibits apoptosis by blocking the processing of CPP32","volume":"1","author":"Slee","year":"1996","journal-title":"Biochem. J."},{"issue":"5","key":"10.1016\/j.cbi.2017.12.003_bib46","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s10495-009-0334-x","article-title":"Necrostatin-1 reverts shikonin-induced necroptosis to apoptosis","volume":"14","author":"Han","year":"2009","journal-title":"Apoptosis"},{"issue":"2","key":"10.1016\/j.cbi.2017.12.003_bib47","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1038\/nchembio711","article-title":"Chemical inhibitor of nonapoptotic cell death with therapeutic potential for ischemic brain injury","volume":"1","author":"Degterev","year":"2005","journal-title":"Nat. Chem. Biol."},{"issue":"1","key":"10.1016\/j.cbi.2017.12.003_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.phymed.2015.11.006","article-title":"Apoptosis and necroptosis induced by stenodactylin in neuroblastoma cells can be completely prevented through caspase inhibition plus catalase or necrostatin-1","volume":"23","author":"Polito","year":"2016","journal-title":"Phytomedicine"}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717310165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279717310165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T19:45:44Z","timestamp":1762112744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279717310165"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":48,"alternative-id":["S0009279717310165"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2017.12.003","relation":{},"ISSN":["0009-2797"],"issn-type":[{"value":"0009-2797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2017.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}